Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.3060
-0.0541 (-15.02%)
At close: Oct 17, 2025, 4:00 PM EDT
0.3099
+0.0039 (1.27%)
After-hours: Oct 17, 2025, 7:57 PM EDT
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $15.41 million as of October 17, 2025. Its market cap has increased by 258.30% in one year.
Market Cap
15.41M
Enterprise Value
8.50M
1-Year Change
258.30%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since November 21, 2013, Processa Pharmaceuticals's market cap has decreased from $17.00M to $15.41M, a decrease of -9.37%. That is a compound annual growth rate of -0.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 15.40M | 431.03% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | -0.43% |
| Dec 31, 2019 | 70.00M | -49.71% |
| Dec 31, 2018 | 139.20M | -10.31% |
| Dec 29, 2017 | 155.20M | 5,442.86% |
| Dec 30, 2016 | 2.80M | -36.36% |
| Dec 31, 2015 | 4.40M | -75.82% |
| Dec 31, 2014 | 18.20M | -32.59% |
| Dec 31, 2013 | 27.00M | 58.82% |
| Nov 21, 2013 | 17.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 715.27B |
| Johnson & Johnson | 465.05B |
| AbbVie | 405.28B |
| UnitedHealth Group | 323.00B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 254.14B |
| Abbott Laboratories | 224.21B |